Skip to content
StockMarketAgent
Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

NSE/HIKAL stock hub

NSE/HIKAL has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

NSE/HIKALis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
26B
National Stock Exchange of India
Market data

Live price

Current market quote for this ticker.

Current price
NSE/HIKAL
In the news

Latest news · NSE/HIKAL

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E32.6
P25 24.9P50 32.4P75 45.7
Trailing P/En/a
P25 24.8P50 35.9P75 56.9
ROEn/a
P25 6.3P50 13.6P75 18.1
ROIC4.2
P25 4.1P50 10.3P75 17.9
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All NSE/HIKAL market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
183
Groups with data
10
Currency
INR
Showing 183 of 183 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
India
Country code
IN
Employees
2,062
Employees Change
1%
Employees Change Percent
0.05
Enterprise value
INR 32.6B
Exchange
National Stock Exchange of India
Financial currency
INR
First seen
2026-05-10
Industry
Drug Manufacturers - Specialty & Generic
Isin
INE475B01022
Last refreshed
2026-05-10
Market cap
INR 26B
Price
INR 211
Price currency
INR
Rev Per Employee
8,465,567.41x
Sector
Healthcare
Sic
2834
Symbol
nse/HIKAL
Website
https://www.hikal.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

11
MetricValue
Earnings Yield
-0.5%
EV Earnings
-251.11x
EV/EBIT
41.37x
EV/EBITDA
14.45x
EV/Sales
1.87x
Forward P/E
32.63x
P/B ratio
2.18x
P/S ratio
1.49x
PE Ratio10 Y
41.12x
PE Ratio3 Y
77.11x
PE Ratio5 Y
61.18x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

18
MetricValue
EBIT Margin
4.52%
EBITDA Margin
12.87%
Gross margin
51.21%
Gross Profit
INR 8.9B
Gross Profit Growth
-2.39%
Gross Profit Growth Q
10.77%
Gross Profit Growth3 Y
2.55%
Gross Profit Growth5 Y
5.05%
Net Income
INR -130M
Net Income Growth Years
1%
Pretax Margin
-1.05%
Profit Margin
-0.74%
Profit Per Employee
INR -63,046
Profitable Years
21
Roa5y
5.65
Roe5y
10.36
ROIC
4.25
Roic5y
8.14

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

16
MetricValue
Cagr10y
8.46%
Cagr15y
12.8%
Cagr1y
-45.57%
Cagr20y
6.03%
Cagr3y
-10.99%
Cagr5y
-8.03%
Div CAGR10
11.61%
Div CAGR3
0%
Div CAGR5
-3.58%
EPS Growth Years
1
Revenue Growth
-4.17x
Revenue Growth Q
10.41x
Revenue Growth Quarters
1x
Revenue Growth Years
1x
Revenue Growth3 Y
-4.11x
Revenue Growth5 Y
2.18x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

13
MetricValue
Cash
INR 193M
Debt
INR 6.8B
Debt EBITDA
INR 3.02
Debt Equity
INR 0.57
Equity
INR 11.9B
Interest Coverage
1.25
Net Cash
INR -6.6B
Net Cash By Market Cap
INR -25.53
Net Debt EBITDA
INR 2.96
Net Debt Equity
INR 0.56
Tangible Book Value
INR 11.9B
Tangible Book Value Per Share
INR 96.28
WACC
6.38

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

9
MetricValue
Buyback Yield
0.26%
Dividend Growth
-16.67%
Dividend Growth Years
1%
Dividend per share
INR 1
Dividend Years
17
Dividend Yield
0.48%
Ex Div Date
2026-02-17
Last Dividend
INR 0.2
Payout Frequency
Semi-Annual

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

37
MetricValue
10Y total return
125.2%
1Y total return
-45.55%
200-day SMA
230
3Y total return
-29.5%
50-day SMA
182.3
50-day SMA vs 200-day SMA
50under200
5Y total return
-34.2%
All Time High
742
All Time High Change
-71.63%
All Time High Date
2021-08-17
All Time Low
6.36
All Time Low Change
3,210.06%
All Time Low Date
2001-11-02
ATR
8.06
Beta
0.34
Ch YTD
-7.19
High
218
High52
449.3
High52 Date
2025-05-14
High52ch
-53.14%
Low
210.1
Low52
146.3
Low52 Date
2026-03-30
Low52ch
43.95%
Ma50ch
15.47%
Price vs 200-day SMA
-8.48%
RSI
70.18
RSI Monthly
40.68
RSI Weekly
49.49
Sharpe ratio
-1.5x
Sortino ratio
-2.02
Total Return
0.74%
Tr YTD
-7.1
Tr15y
509%
Tr1m
27.45%
Tr1w
8.11%
Tr3m
17.38%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

6
MetricValue
Operating Income
INR 789M
Operating Income Growth
-53.77
Operating Income Growth Q
6.68
Operating Income Growth3 Y
-14.84
Operating Income Growth5 Y
-16.96
Operating margin
4.52

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

5
MetricValue
Float
38,077,520%
Shares Insiders
9.97%
Shares Institutions
9.2%
Shares Qo Q
-0.33%
Shares Yo Y
-0.26%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

48
MetricValue
Average Volume
330,977.1x
Bv Per Share
96.84
Ch10y
111.9
Ch15y
438.8
Ch1m
27.45
Ch1w
8.11
Ch1y
-45.77
Ch20y
168.2
Ch3m
17.27
Ch3y
-30.3
Ch5y
-35.46
Ch6m
-9.21
Change
-1.12%
Change From Open
-1.14
Close
212.9
Days Gap
0.02
Depreciation Amortization
1,457,000,000
Dollar Volume
71,905,421.7
Earnings Date
2026-05-15
EBIT
INR 789M
EBITDA
INR 2.2B
EPS
INR -1.06
F Score
1
Fiscal Year End
March
Founded
1,988
Income Tax
INR -53M
Is Primary Listing
0
Last Earnings Date
2026-02-04
Last Report Date
2025-12-31
Last Split Date
2018-06-22
Last Split Type
Forward
Ma150
212
Ma150ch
-0.68%
Ma20
191
Ma20ch
10.2%
Next Earnings Date
2026-05-15
Open
213
Payment Date
2026-03-12
Position In Range
5.32
Price Date
2026-05-08
Price EBITDA
INR 11.58
Ptbv Ratio
2.19
Relative Volume
1.02x
Revenue
17,456,000,000x
Tax By Revenue
-0.3x
Tr20y
222.63%
Tr6m
-9.12%
Volume
341,561
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

NSE/HIKAL dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield
+0.5%
$1.00 annual per share
Payout ratio
n/a
Share of earnings returned as dividends. Below 60% is generally sustainable.
5Y dividend CAGR
-3.6%
1 consecutive years of growth
Total shareholder yield
+0.7%
Next ex-dividend date: 2026-02-17
Performance

NSE/HIKAL stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-45.5%
S&P 500 1Y: n/a
3Y total return
-29.5%
S&P 500 3Y: n/a
5Y total return
-34.2%
S&P 500 5Y: n/a
10Y total return
+125.2%
S&P 500 10Y: n/a
Ownership

Who owns NSE/HIKAL?

Insider, institutional, and short-interest positioning.

Institutional ownership
+9.2%
Share of float held by funds and institutions
Insider ownership
+10.0%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
-0.3%
Negative means the company is buying back shares.
Technical

NSE/HIKAL momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
70.2
Above 70: short-term overbought
Price vs 200-day MA
-8.5%
50/200-day relationship not available
Beta (5Y)
0.34
Less volatile than the market
Sharpe ratio
-1.50
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About NSE/HIKAL

Hub-level FAQ points readers to the deeper analysis pages.

What is the current nse/HIKAL stock rating?

nse/HIKAL is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full nse/HIKAL analysis?

The full report lives at /stocks/nse/HIKAL/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for nse/HIKAL?

The latest report frames nse/HIKAL around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the nse/HIKAL page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.

nse/HIKAL stock profile: metrics, valuation and analysis | Agente de Mercado de Ações com IA